Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-19 Sale | 2025-12-19 5:04 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $4.5 | $180,000 | 9,679,176 (Indirect Direct) | View |
| 2025-12-04 Sale | 2025-12-05 7:20 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $4.63 | $185,200 | 9,719,176 (Indirect Direct) | View |
| 2025-12-02 Sale | 2025-12-04 4:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 220,000 | $4.37 | $961,400 | 6,869,863 (Direct) | View |
| 2025-11-19 Sale | 2025-11-19 7:37 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $4.16 | $166,400 | 9,779,176 (Indirect Direct) | View |
| 2025-11-04 Sale | 2025-11-06 4:23 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $5.21 | $208,400 | 9,859,566 (Indirect Direct) | View |
| 2025-10-23 Sale | 2025-10-24 6:49 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $5.7 | $570,000 | 9,919,566 (Indirect Direct) | View |
| 2025-10-10 Sale | 2025-10-10 6:03 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $6.04 | $604,000 | 10,129,266 (Indirect Direct) | View |
| 2025-09-25 Sale | 2025-09-26 6:32 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $4.76 | $476,000 | 10,249,266 (Indirect Direct) | View |
| 2025-09-10 Sale | 2025-09-12 4:24 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $4.71 | $471,000 | 10,249,266 (Indirect Direct) | View |
| 2025-08-26 Sale | 2025-08-28 8:00 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $4.84 | $484,000 | 10,369,266 (Indirect Direct) | View |
| 2025-08-18 Sale | 2025-08-19 6:22 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer | 36,599 | $5.524 | $202,173 | 668,197 (Direct) | View |
| 2025-08-11 Sale | 2025-08-13 9:03 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 618,175 | $5.28 | $3,263,964 | 10,509,656 (Indirect Direct) | View |
| 2025-03-27 Sale | 2025-03-28 4:52 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 138,574 | $6.04 | $836,987 | 11,174,028 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-19 Conversion | 2025-12-19 5:04 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 9,679,176 (Direct) | View |
| 2025-12-15 Tax Withholding | 2025-12-17 6:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $4.33 | 782,933 (Direct) | View |
| 2025-12-04 Conversion | 2025-12-05 7:20 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 60,000 | $0 | 9,719,176 (Direct) | View |
| 2025-12-04 Gift | 2025-12-05 7:20 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 20,000 | $0 | 9,719,176 (Direct) | View |
| 2025-11-25 Tax Withholding | 2025-11-26 5:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 2,271 | $4.03 | 789,990 (Direct) | View |
| 2025-11-17 Tax Withholding | 2025-11-19 7:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,908 | $4.14 | 792,261 (Direct) | View |
| 2025-11-17 Tax Withholding | 2025-11-19 7:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer | 17,584 | $4.14 | 735,538 (Direct) | View |
| 2025-11-17 Tax Withholding | 2025-11-19 7:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,390 | $4.14 | 9,779,176 (Direct) | View |
| 2025-11-19 Conversion | 2025-11-19 7:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 9,779,176 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-06 4:23 pm | N/A 2035-11-05 | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer | 254,776 | $0 | 922,973 (Direct) | View |
| 2025-11-04 Conversion | 2025-11-06 4:23 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 60,000 | $0 | 9,859,566 (Direct) | View |
| 2025-11-04 Gift | 2025-11-06 4:23 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 20,000 | $0 | 9,859,566 (Direct) | View |
| 2025-10-23 Conversion | 2025-10-24 6:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $0 | 9,919,566 (Direct) | View |
| 2025-10-10 Conversion | 2025-10-10 6:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 120,000 | $0 | 10,129,266 (Direct) | View |
| 2025-10-10 Gift | 2025-10-10 6:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 20,000 | $0 | 10,129,266 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:27 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 1,961 | $0 | 3,218,557 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:27 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 2,941 | $0 | 138,758 (Direct) | View |
| 2025-09-25 Conversion | 2025-09-26 6:32 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $0 | 10,249,266 (Direct) | View |
| 2025-09-15 Tax Withholding | 2025-09-17 4:45 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $4.83 | 804,169 (Direct) | View |
| 2025-09-10 Conversion | 2025-09-12 4:24 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 120,000 | $0 | 10,249,266 (Direct) | View |
| 2025-09-10 Gift | 2025-09-12 4:24 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 20,000 | $0 | 10,249,266 (Direct) | View |
| 2025-08-26 Conversion | 2025-08-28 8:00 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $0 | 10,369,266 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-19 6:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,908 | $5.64 | 811,226 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-19 6:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,390 | $5.64 | 954,229 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-19 6:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer | 3,789 | $5.64 | 668,197 (Direct) | View |
| 2025-08-11 Conversion | 2025-08-13 9:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 541,541 | $0 | 10,509,656 (Direct) | View |
| 2025-08-11 Gift | 2025-08-13 9:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,509,656 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 3:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 1,949 | $0 | 3,216,596 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 3:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 2,924 | $0 | 135,817 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 5:23 pm | N/A 2035-06-18 | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 66,047 | $0 | 7,133,894 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 5:23 pm | N/A 2035-06-18 | RECURSION PHARMACEUTICALS INC. | RXRX | Michor Franziska Director | 66,047 | $0 | 171,084 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 5:23 pm | N/A 2035-06-18 | RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director | 66,047 | $0 | 117,763 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 5:23 pm | N/A 2035-06-18 | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 66,047 | $0 | 176,924 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 5:23 pm | N/A 2035-06-18 | RECURSION PHARMACEUTICALS INC. | RXRX | Bumpus Namandje Director | 33,024 | $0 | 69,573 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 5:22 pm | N/A 2035-06-18 | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 66,047 | $0 | 3,258,678 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 5:22 pm | N/A 2035-06-18 | RECURSION PHARMACEUTICALS INC. | RXRX | Sun Elaine D Director | 33,024 | $0 | 69,573 (Direct) | View |
| 2025-06-16 Tax Withholding | 2025-06-18 4:32 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $4.92 | 2,097,596 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-05-19 4:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer | 3,796 | $4.25 | 2,122,755 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-05-19 4:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,908 | $4.25 | 2,104,653 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-05-19 4:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 36,197 | $4.25 | 11,137,831 (Direct) | View |
| 2025-04-01 Tax Withholding | 2025-04-03 4:38 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 26,571 | $5.095 | 2,116,561 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 2,268 | $0 | 3,192,462 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 2,745 | $0 | 110,877 (Direct) | View |
| 2025-03-17 Tax Withholding | 2025-03-19 4:27 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $6.84 | 2,143,132 (Direct) | View |